Hojo Hiroshi, Sasaki Yoshikazu, Nakamura Naoya, Sato Michiko, Abe Masafumi
First Department of Pathology, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, 960-1295, Japan.
Pediatr Dev Pathol. 2004 May-Jun;7(3):250-7. doi: 10.1007/s10024-003-8085-0. Epub 2004 Mar 17.
Somatic mutation (SM) analysis provides a useful tool for understanding the stages at which neoplastic differentiate from normal B-cells. B-cell precursor neoplasms are considered to be somatically premutational. However, the variable frequency of SM of the variable region (VH) genes has been described in cases of precursor B-cell acute lymphoblastic leukemia (PB-ALL). To better characterize PB-ALL based on the differentiation stage, we investigated the SM of the VH genes expressed by tumor cells of the surface immunoglobulin (sIg)(-) HBL-3 cell line derived from childhood PB-ALL. In the HBL-3 cell line, the rearranged Ig heavy chain VH gene sequence showed no SM in the complementarity-determining regions of 1, 2, and 3, or in the framework regions of 1, 2, and 3 relative to the putative germline VH gene sequences. In addition, the VH segment of HBL-3 cells showed no intraclonal sequence heterogeneity, indicating ongoing SM. Our data demonstrated that HBL-3 cells express unmutated and developmentally regulated rearrangement of VH genes at the stage of B-cell precursor cells. HBL-3 cells, which are derived only from the sIg(-) PB-ALL, showed that SM cannot be recognized in VH genes of tumor cells before the expression of sIg.
体细胞突变(SM)分析为理解肿瘤细胞从正常B细胞分化的阶段提供了一个有用的工具。B细胞前体肿瘤被认为是体细胞预突变的。然而,在前体B细胞急性淋巴细胞白血病(PB-ALL)病例中,已描述了可变区(VH)基因的SM频率存在差异。为了基于分化阶段更好地表征PB-ALL,我们研究了源自儿童PB-ALL的表面免疫球蛋白(sIg)(-)HBL-3细胞系肿瘤细胞所表达的VH基因的SM。在HBL-3细胞系中,相对于推定的种系VH基因序列,重排的Ig重链VH基因序列在互补决定区1、2和3以及框架区1、2和3中均未显示SM。此外,HBL-3细胞的VH区段未显示克隆内序列异质性,表明正在进行SM。我们的数据表明,HBL-3细胞在B细胞前体细胞阶段表达未突变且受发育调控的VH基因重排。仅源自sIg(-)PB-ALL的HBL-3细胞表明,在sIg表达之前,肿瘤细胞的VH基因中无法识别SM。